Alamo, CA, United States of America

Poornima Dwivedi


Average Co-Inventor Count = 11.3

ph-index = 3

Forward Citations = 35(Granted Patents)


Location History:

  • Medfield, MA (US) (2001)
  • Alamo, CA (US) (2007)

Company Filing History:


Years Active: 2001-2007

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Poornima Dwivedi: Innovator in Genetic Research

Introduction

Poornima Dwivedi is a distinguished inventor based in Alamo, California. She has made significant contributions to the field of genetic research, particularly in the area of cancer diagnostics and therapeutics. With a total of three patents to her name, her work has the potential to impact medical science profoundly.

Latest Patents

Dwivedi's latest patents include a method for detecting a differentially expressed sequence. This invention relates to novel human genes, proteins expressed by these genes, and variants of the proteins. It also encompasses diagnostic assays and therapeutic agents related to the genes and proteins, including probes, antisense constructs, and antibodies. The subject nucleic acids have been found to be differentially regulated in tumor cells, particularly in colon cancer tissue. Another significant patent is focused on human genes and gene expression products, which shares similar themes of novel human genes and their applications in diagnostics and therapeutics.

Career Highlights

Throughout her career, Poornima Dwivedi has worked with prominent organizations such as Bayer Corporation and the Mayo Foundation for Medical Education and Research. Her experience in these institutions has allowed her to develop her innovative ideas and contribute to groundbreaking research in genetics.

Collaborations

Some of her notable coworkers include Jon H Astle and Christopher C Burgess. Their collaboration has likely enriched her research endeavors and expanded the impact of her inventions.

Conclusion

Poornima Dwivedi's work exemplifies the intersection of innovation and medical science. Her patents not only advance our understanding of genetic expressions but also pave the way for new diagnostic and therapeutic approaches in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…